Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $107

Benzinga Newsdesk www.benzinga.com Positive 78.2%

Neg 0% Neu 0% Pos 78.2%

Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $60 to $107.